Commonwealth Equity Services LLC Raises Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Commonwealth Equity Services LLC grew its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 3,263.8% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 314,043 shares of the medical instruments supplier’s stock after purchasing an additional 304,707 shares during the quarter. Commonwealth Equity Services LLC’s holdings in DENTSPLY SIRONA were worth $5,961,000 as of its most recent filing with the SEC.

Several other hedge funds also recently made changes to their positions in XRAY. Pacer Advisors Inc. grew its holdings in shares of DENTSPLY SIRONA by 15,105.1% during the fourth quarter. Pacer Advisors Inc. now owns 4,503,591 shares of the medical instruments supplier’s stock worth $85,478,000 after purchasing an additional 4,473,972 shares during the last quarter. Cooke & Bieler LP grew its holdings in shares of DENTSPLY SIRONA by 24.3% during the fourth quarter. Cooke & Bieler LP now owns 9,172,876 shares of the medical instruments supplier’s stock worth $174,101,000 after buying an additional 1,794,391 shares during the last quarter. JPMorgan Chase & Co. grew its holdings in shares of DENTSPLY SIRONA by 206.3% during the third quarter. JPMorgan Chase & Co. now owns 1,847,389 shares of the medical instruments supplier’s stock worth $49,990,000 after buying an additional 1,244,326 shares during the last quarter. Invenomic Capital Management LP purchased a new position in shares of DENTSPLY SIRONA during the third quarter worth about $23,724,000. Finally, National Bank of Canada FI grew its holdings in shares of DENTSPLY SIRONA by 85.8% during the third quarter. National Bank of Canada FI now owns 1,628,200 shares of the medical instruments supplier’s stock worth $44,059,000 after buying an additional 751,800 shares during the last quarter. Hedge funds and other institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Price Performance

XRAY stock opened at $15.56 on Friday. The firm has a 50 day moving average of $17.92 and a 200-day moving average of $20.53. DENTSPLY SIRONA Inc. has a 12-month low of $14.78 and a 12-month high of $33.52. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. The company has a market cap of $3.10 billion, a price-to-earnings ratio of -7.52, a PEG ratio of 1.80 and a beta of 0.98.

DENTSPLY SIRONA Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 28th will be given a dividend of $0.16 per share. The ex-dividend date is Friday, March 28th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 4.11%. DENTSPLY SIRONA’s payout ratio is -14.07%.

Insider Activity

In related news, Director Gregory T. Lucier acquired 15,142 shares of the business’s stock in a transaction that occurred on Monday, March 3rd. The stock was purchased at an average cost of $16.51 per share, for a total transaction of $249,994.42. Following the transaction, the director now directly owns 81,971 shares of the company’s stock, valued at approximately $1,353,341.21. This trade represents a 22.66 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Insiders own 0.52% of the company’s stock.

Analyst Upgrades and Downgrades

XRAY has been the topic of a number of research reports. Needham & Company LLC reissued a “hold” rating on shares of DENTSPLY SIRONA in a report on Thursday, March 13th. Wells Fargo & Company lowered their price target on DENTSPLY SIRONA from $20.00 to $19.00 and set an “equal weight” rating on the stock in a report on Friday, February 28th. StockNews.com lowered DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Friday, February 28th. Evercore ISI reaffirmed an “in-line” rating and issued a $20.00 price objective on shares of DENTSPLY SIRONA in a report on Tuesday, January 7th. Finally, Jefferies Financial Group lowered DENTSPLY SIRONA from a “buy” rating to a “hold” rating and lowered their price objective for the company from $30.00 to $20.00 in a report on Thursday, January 23rd. Twelve investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $23.33.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.